Loading...
Browse all stories on DeepNewz
Visit
Moderna Wins European Patent Dispute Against Pfizer, BioNTech Over COVID-19 Vaccine in Legal Battle
May 17, 2024, 10:30 PM
Moderna has emerged victorious in a European patent dispute against Pfizer and BioNTech over its COVID-19 vaccine. The European Patent Office upheld Moderna's key patent, marking a significant win in the ongoing legal battle with its rivals.
View original story
Markets
No • 50%
Yes • 50%
Official court records or public statements from the companies
No • 50%
Yes • 50%
Official announcements from legal teams or court records
Yes • 50%
No • 50%
Financial market data and stock performance records
Acceleration in new mRNA vaccine entries • 25%
Increased legal battles over mRNA technologies • 25%
Shift towards non-mRNA vaccine technologies • 25%
Stagnation due to legal uncertainties • 25%
Global health organization reports and vaccine development updates
Decreased Pfizer/BioNTech market share • 33%
Increased Moderna market share • 33%
No significant change • 34%
Public announcements from vaccine distributors and healthcare providers
Both companies form new partnerships • 25%
No new partnerships formed • 25%
Moderna forms new partnerships • 25%
Pfizer/BioNTech forms new partnerships • 25%
Press releases and official company announcements